Publicado

2022-03-01

Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia

Anticonceptivos, enfermedad crónica, embarazo y costos de salud en un seguro de salud en Colombia

DOI:

https://doi.org/10.15446/rsap.v24n2.89316

Palavras-chave:

Costs and cost analysis, health economics, epidemiology, chronic disease, pregnancy (en)
Costos y análisis de costos, economía de la salud, epidemiología, enfermedad crónica, embarazo (es)

Downloads

Autores

Objetive Evaluation of the impact of pregnancy on women with a high disease burden, especially with Chronic Non-Communicable Diseases (CNCD) in the costs of a health insurer.

Materials and Methods Retrospective costing study conducted at Famisanar EPS between 2016 and 2018. We used multiple linear regression models to evaluate; the overall costs were calculated for each patient. The insurer's perspective was taken into account for the analysis.

Results The study universe was made up of 458 249 women of childbearing age affiliated to Famisanar EPS between 15 and 49 years, of which 24 030 (5.2%) women have some relationship with the CNCD, of these, 2 454 (10.2%) went to childbirth and caesarean section. We had determined the costs of pregnancy healthy´s women in U$200.41 and pregnancy CNCD´s women U$519.95 (97.5%) in terms of the costs for the complication’s gestation care. Using multinomial regression, we compared the pregnancy with CNCD with the other groups of women. We did not observe any significant differences in ingress and zone. However, we observe signicant differences in the age.

Conclusion Pre-existing CNCD in pregnant women can lead to the use of additional resources in the health system. CNCD in society represent a severe burden for a health system due to high costs and especially when talking about women who have an CNCD and are in pregnant. The study also indicates that female infertility treatments are important for cost containment in health systems.

Objetivo Evaluación del impacto del embarazo en mujeres con una alta carga de enfermedad, especialmente con Enfermedades Crónicas No Transmisibles (ECNT) en los costos de una aseguradora de salud.

Materiales y Métodos Estudio de costos retrospectivos realizado en Famisanar EPS entre 2016 y 2018. Utilizamos múltiples modelos de regresión lineal para evaluar; los costos generales se calcularon para cada paciente. La perspectiva de la aseguradora fue considerada para el análisis.

Resultados El universo de estudio estuvo conformado por 458 249 mujeres en edad fértil afiliadas a Famisanar EPS entre 15 y 49 años de edad, de las cuales 24 030 (5,2%) mujeres tienen alguna relación con el ECNT, de estas, 2 454 (10,2%) fueron al parto y cesárea. Habíamos determinado los costos del embarazo en mujeres sanas en U$ 200,41 y el embarazo en mujeres con ECNT U$ 519,95 (97,5%) en términos de los costos de las complicaciones en la atención de gestación. Mediante la regresión multinomial, comparamos los embarazos de ECNT con los otros grupos de mujeres. No observamos diferencias significativas en zona e ingresos, observamos diferencias significativas en la edad.

Conclusión El ECNT preexistente en mujeres embarazadas puede conducir al uso de recursos adicionales en el sistema de salud. El ECNT en la sociedad representa una carga severa para un sistema de salud debido a los altos costos y especialmente cuando se habla de mujeres que tienen un ECNT y están embarazadas.

 

Referências

Toirac L, Pascual L, Martínez J, Area S. Macrosomía fetal en madres no diabéticas. Caracterización mínima. MediSan [Internet]. 2013 [cited 2020 Mar 2]; 17(10):6052-62. https://bit.ly/3NyCw0w.

Chatterjee S, Kotelchuck M, Sambamoorthi U. Prevalence of chronic illness in pregnancy, access to care, and health care costs: implications for interconception care. Women's Health Issues. 2008; 18(6):S107-S116. https://doi.org/10.1016/j.whi.2008.06.003. DOI: https://doi.org/10.1016/j.whi.2008.06.003

Arribas-Entrala B, Arribas-Mir L, Ruiz-Cabello C. Enfermedades crónicas y embarazo (III): Diabetes mellitus y obesidad. Revista Medica MD. 2016; 4(4):270.

Torloni M, Betrán A, Horta B, Nakamura M, Atallah A, Moron A. Prepregnancy BMI and the risk of gestational diabetes: A systematic review of the literature with meta-analysis. Obes Rev. 2009; 10, 194- 203. https://doi.org/10.1111/j.1467-789x.2008.00541.x. DOI: https://doi.org/10.1111/j.1467-789X.2008.00541.x

Tsoi E, Shaikh H, Robinson S, Teoh T. Obesity in pregnancy: A major healthcare issue. Postgrad Med J. 2010; 86:617-23. https://doi.org/10.1136/pgmj.2010.098186. DOI: https://doi.org/10.1136/pgmj.2010.098186

Ehrenberg H, Mercer B, Catalano P. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191:964-68. https://doi.org/10.1016/j.ajog.2004.05.052. DOI: https://doi.org/10.1016/j.ajog.2004.05.052

Reyes E, Martínez N, Parra A, Castillo-Mora A, Ortega-González C. Early intensive obstetric and medical nutrition care is associated with decreased prepregnancy obesity impact on perinatal outcomes. Gynecol Obstet Invest. 2012; 73:75-81. https://doi.org/10.1159/000329899. DOI: https://doi.org/10.1159/000329899

González-Moreno J, Juárez-López J, Rodríguez-Sánchez J. Obesidad y embarazo. Revista médica MD. 2013; 4(4):270-6.

Sanchez P, Baeyens J, Arribas L. Enfermedades crónicas y embarazo II: migraña, hipertensión arterial e hipotiroidismo. Hier Medicina Clínica [cited 2020 Mar 2]. 2016 [cited 2020 Mar 2]; 146(1):35-9. DOI: https://doi.org/10.1016/j.medcli.2015.07.003

Langer A. El embarazo no deseado: impacto sobre la salud y la sociedad en América Latina y el Caribe. Rev Panam Salud Publica [Internet]. 2002 [cited 2020 Mar 2]; 11(3):192-204. https://bit.ly/3OQBttX. DOI: https://doi.org/10.1590/S1020-49892002000300013

Cardona A, Cortés MVM, Díaz Y, Varela R, Figueroa D. Proyecto de atención preventiva de mujeres con alto riesgo reproductivo. Perinatología y Reproducción Humana. 2017; 31(2):96-104. https://doi.org/10.1016/j.rprh.2017.11.001. DOI: https://doi.org/10.1016/j.rprh.2017.11.001

Gorbanev I, Cortés A, Agudelo S, Yepes F. ¿Por qué los grupos relacionados de diagnóstico no se implementan en Colombia? Cadernos de Saúde Pública. 2015; 31:2027-31. https://doi.org/10.1590/0102-311X00170114. DOI: https://doi.org/10.1590/0102-311X00170114

Chodick G, Porath A, Alapi H, Sella T, Flash S, Wood F, et al. The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel. Health Policy. 2010; 95(2-3):271-6. https://doi.org/10.1016/j.healthpol.2009.12.007. DOI: https://doi.org/10.1016/j.healthpol.2009.12.007

Weisman C, Hillemeier M, Chase G, Dyer A, Baker S, Feinberg M. Preconceptional health: Risks of adverse pregnancy outcomes by reproductive life stage in the Central Pennsylvania Women's Health Study (CePAWHS). Women's Health Issues. 2006; 16:216-24. https://doi.org/10.1016/j.whi.2006.01.001. DOI: https://doi.org/10.1016/j.whi.2006.01.001

Holton S, Thananjeyan A, Rowe H, Kirkman M, Jordan L, McNamee K, et al. The fertility management experiences of Australian women with a non-communicable chronic disease: findings from the understanding fertility management in contemporary Australia survey. Maternal and child health journal. 2018; 22(6):830-40. https://doi.org/10.1007/s10995-018-2454-9. DOI: https://doi.org/10.1007/s10995-018-2454-9

Law A, McCoy M, Lynen R, Curkendall S, Gatwood J, Juneau P, et al. The additional cost burden of preexisting medical conditions during pregnancy and childbirth. Journal of Women's Health. 2015; 24(11):924-32. https://doi.org/10.1089/jwh.2014.4951. DOI: https://doi.org/10.1089/jwh.2014.4951

Jovanovič L, Liang Y, Weng W, Hamilton M, Chen L, Wintfeld N. Diabetes/metabolism research and reviews. Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy. 2015; 31(7):707-16. https://doi.org/10.1002/dmrr.2656. DOI: https://doi.org/10.1002/dmrr.2656

Cohen J, Krauss N. Spending and service use among people with the fifteen most costly medical conditions 1997. Health Aff (Millwood). 2003; 22:129-38. DOI: https://doi.org/10.1377/hlthaff.22.2.129

Barton J, Istwan N, Rhea D, Collins A, Stanziano G. Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. Disease Management. 2006; 9(4):236-41. https://doi.org/10.1089/dis.2006.9.236. DOI: https://doi.org/10.1089/dis.2006.9.236

Morgan K, Rahman M, Macey S, Atkinson M, Hill R, Khanom A, et al. Obesity in pregnancy: a retrospective prevalence-based study on health service utilisation and costs on the NHS. BMJ open [Internet]. 2014 [cited 2020 Mar 2]; 4(2):e003983. https://bit.ly/3RctVnF. DOI: https://doi.org/10.1136/bmjopen-2013-003983

Cortés A, Yepes F, Agudelo S, Gorbanev Y. El sistema de salud colombiano: Grupos relacionados de diagnóstico. Bogotá: Javeriana; 2018.

Como Citar

APA

Cortés, A. E., Realpe, O., Fuerte, M. I., Tello, P. A. e Becerra, C. E. (2022). Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia. Revista de Salud Pública, 24(2), 1–7. https://doi.org/10.15446/rsap.v24n2.89316

ACM

[1]
Cortés, A.E., Realpe, O., Fuerte, M.I., Tello, P.A. e Becerra, C.E. 2022. Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia. Revista de Salud Pública. 24, 2 (mar. 2022), 1–7. DOI:https://doi.org/10.15446/rsap.v24n2.89316.

ACS

(1)
Cortés, A. E.; Realpe, O.; Fuerte, M. I.; Tello, P. A.; Becerra, C. E. Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia. Rev. salud pública 2022, 24, 1-7.

ABNT

CORTÉS, A. E.; REALPE, O.; FUERTE, M. I.; TELLO, P. A.; BECERRA, C. E. Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia. Revista de Salud Pública, [S. l.], v. 24, n. 2, p. 1–7, 2022. DOI: 10.15446/rsap.v24n2.89316. Disponível em: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/89316. Acesso em: 22 jan. 2025.

Chicago

Cortés, Ariel Emilio, Oscar Realpe, María Isabel Fuerte, Paula Andrea Tello, e Carmen Elisa Becerra. 2022. “Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia”. Revista De Salud Pública 24 (2):1-7. https://doi.org/10.15446/rsap.v24n2.89316.

Harvard

Cortés, A. E., Realpe, O., Fuerte, M. I., Tello, P. A. e Becerra, C. E. (2022) “Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia”, Revista de Salud Pública, 24(2), p. 1–7. doi: 10.15446/rsap.v24n2.89316.

IEEE

[1]
A. E. Cortés, O. Realpe, M. I. Fuerte, P. A. Tello, e C. E. Becerra, “Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia”, Rev. salud pública, vol. 24, nº 2, p. 1–7, mar. 2022.

MLA

Cortés, A. E., O. Realpe, M. I. Fuerte, P. A. Tello, e C. E. Becerra. “Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia”. Revista de Salud Pública, vol. 24, nº 2, março de 2022, p. 1-7, doi:10.15446/rsap.v24n2.89316.

Turabian

Cortés, Ariel Emilio, Oscar Realpe, María Isabel Fuerte, Paula Andrea Tello, e Carmen Elisa Becerra. “Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia”. Revista de Salud Pública 24, no. 2 (março 1, 2022): 1–7. Acessado janeiro 22, 2025. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/89316.

Vancouver

1.
Cortés AE, Realpe O, Fuerte MI, Tello PA, Becerra CE. Contraceptives, chronic illness, pregnancy and health care costs in one health insurance in Colombia. Rev. salud pública [Internet]. 1º de março de 2022 [citado 22º de janeiro de 2025];24(2):1-7. Disponível em: https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/89316

Baixar Citação

CrossRef Cited-by

CrossRef citations0

Dimensions

PlumX

Acessos à página de resumo

277

Downloads

Não há dados estatísticos.